Does Insurance Cover Wegovy, Zepbound or Ozempic?

On this page

• What each drug is approved for
• Why the diagnosis matters
• Employer plans
• Marketplace plans
• Medicare
• Medicaid
• Typical prior approval rules
• If your plan won’t pay
• Frequently asked questions

What each drug is approved for

Drug	Maker	Form	FDA-approved for
Ozempic	Novo Nordisk	Weekly injection or daily pill	Type 2 diabetes, including lowering heart and kidney risks for some people with diabetes
Wegovy	Novo Nordisk	Weekly injection or daily pill	Weight management, and lowering heart attack and stroke risk in some people; the injection is also approved for a type of fatty liver disease (MASH)
Mounjaro	Eli Lilly	Weekly injection	Type 2 diabetes
Zepbound	Eli Lilly	Weekly injection	Weight management, and sleep apnea in adults with obesity
Foundayo	Eli Lilly	Daily pill	Weight management

Ozempic and Wegovy contain the same medicine, semaglutide, and Mounjaro and Zepbound both contain tirzepatide. They’re sold under different names for different uses, and insurance treats them differently.

Why the diagnosis matters

Most plans cover diabetes drugs, so if you have type 2 diabetes, Ozempic or Mounjaro is usually on the drug list, often with prior approval. See can I get health insurance if I have diabetes.

Weight-loss coverage is different. Many plans treat drugs for weight management as an optional benefit and leave them out. Plans check the diagnosis, so a diabetes drug usually won’t be covered when it’s prescribed for weight loss.

Employer plans

Coverage for weight loss varies a lot from one employer to the next, and it’s shrinking at some:

• In a 2026 survey by the International Foundation of Employee Benefit Plans, 36% of employers covered GLP-1s for both diabetes and weight loss, and 60% covered them for diabetes only.
• Among large employers surveyed by the Business Group on Health, coverage for obesity fell from 72% in 2025 to 60% in 2026.
• Massachusetts stopped covering the drugs for weight loss in its state employee plan starting in July 2026, and North Carolina’s state employee plan stopped in 2024.

If your employer covers them, expect prior approval and rules about staying on the drug. Ask HR or check your plan’s drug list.

Marketplace plans

Coverage for weight loss varies by plan, and many Marketplace plans don’t include it. If you need one of these drugs, look it up in each plan’s drug list before you enroll. See does health insurance cover prescription drugs.

Medicare

By law, Medicare drug plans can’t cover drugs used only for weight loss. They can cover GLP-1s for other approved uses, like Ozempic or Mounjaro for diabetes, Wegovy to lower heart risk in people with heart disease, and Zepbound for sleep apnea.

The Medicare GLP-1 Bridge started July 1, 2026. It covers Wegovy (injection or pill), the Zepbound KwikPen and Foundayo for weight management for a $50 copay per month’s supply. You may qualify if you have:

• A BMI of 35 or higher, or
• A BMI of 30 to 34.9 with heart failure, high blood pressure or chronic kidney disease, or
• A BMI of 27 to 29.9 with prediabetes, a past heart attack or stroke, or peripheral artery disease

People who have type 2 diabetes, moderate to severe sleep apnea or fatty liver disease get these drugs through their Part D plan instead. The Bridge runs outside Part D, so the $50 doesn’t count toward your Part D deductible or out-of-pocket cap. It’s temporary, and approvals last through December 31, 2027.

Starting January 1, 2027, Medicare’s negotiated price for Ozempic, Wegovy and Rybelsus also takes effect in Part D. If you’re reviewing drug plans this fall, see Medicare open enrollment.

Medicaid

As of January 2026, 13 state Medicaid programs covered GLP-1s for obesity. California, New Hampshire, Pennsylvania and South Carolina ended that coverage on January 1, 2026, though they still cover the drugs for diabetes. North Carolina dropped it in October 2025 and brought it back in December 2025. A federal program called BALANCE lets states cover the drugs at negotiated prices, and states can join through January 1, 2027.

Typical prior approval rules

Plans that cover these drugs for weight loss usually follow the FDA label: a BMI of 30 or more, or 27 or more with a weight-related condition like high blood pressure. Many also require proof that you’re in a diet and exercise program, and some approve the drug for several months at a time and want to see at least 5% weight loss before renewing. Some plans set a higher BMI bar. See what is prior authorization.

If you’re denied, you can appeal, especially if you have a condition the drug is approved to treat. See how to appeal a health insurance claim denial.

If your plan won’t pay

Both drugmakers now sell directly to patients at lower cash prices:

Drug	Self-pay price per month
Wegovy pen	$349 ($199 for the first two fills for new patients); $399 for the highest dose
Wegovy pill	$149 to $299, depending on dose
Zepbound	$299 to $449 if refilled on time
Foundayo	$149 to $299, depending on dose

These cash prices don’t count toward your insurance deductible. Manufacturer savings cards for people with commercial insurance can’t be used if you have Medicare, Medicaid or other government coverage. Prescription drugs for a diagnosed medical condition, including obesity, generally count as medical expenses, so you may be able to use HSA or FSA money. See what is an HSA and will health insurance pay for weight loss programs.

Shopping for a plan that covers your prescriptions? Compare plans in your area.

Frequently asked questions

Does insurance cover Ozempic for weight loss?

Usually not. Ozempic is approved for type 2 diabetes, and plans cover it for that. For weight loss, doctors prescribe Wegovy, which has the same active ingredient.

Does Medicare cover Wegovy?

Part D plans can cover Wegovy to lower heart risk in people with heart disease. For weight loss, eligible people can get it through Medicare’s GLP-1 Bridge for $50 a month.

How much is Wegovy without insurance?

From the maker, $349 a month for the pen after a $199 introductory price for the first two fills, and $149 to $299 a month for the pill.

Will my plan cover Zepbound for sleep apnea?

It may, since sleep apnea is an approved use. Plans that exclude weight-loss drugs sometimes cover Zepbound for moderate to severe sleep apnea with prior approval.

This article is general information, not medical advice. Talk with your doctor about whether these drugs are right for you. Prices and coverage change often. Last reviewed September 2026.